newsfilter
← Latest News
Business Wire·

NeoGenomics Reports First Quarter 2026 Results

First quarter total revenue increased 11% YoY to $187 million; Clinical revenue grew 14%, including NGS growth of 26%; Company announces increase in full-year 2026 revenue guidance to a range of $797-$803